High-resolution crystal structures of AB(5) toxins in their native form or
in complex with a variety of ligands have led to the structure-based design
and discovery of inhibitors targeting different areas of the toxins. The m
ost significant progress is the development of highly potent multivalent li
gands that block binding of the toxins to their receptors.